News

Businesses innovating in Scotland’s thriving bio-based manufacturing industry are being invited to apply for support packages of between £25,000 and £1 million as Innovate UK opens Round 2 of its pioneering Launchpad funding programme. 

Scottish Widows inducted the second wave of future tech stars on Tuesday 29 October at its Dundee Tech School, following the success its first year of trainees achieved.

Dr. Falk Pharma GmbH today announced completion of the acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on the development of novel KMO inhibitors for acute and chronic inflammatory diseases.

Montrose Port Authority (MPA) is set to embark on a major expansion with the acquisition of Montrose Commercial Park and the adjacent former Charleton Maternity Home site.

Twelve Scottish business founders are being given the opportunity to showcase their products and attract international investment in one of the world’s biggest tech economies.

Neuranics has secured an £800,000 grant from Scottish Enterprise (SE) to support a £2.4 million project aimed at transforming how humans interact with machines through innovative wristband technology.

A new £7.9m investment, led by £3.5m from the Scottish National Investment Bank, will enable scale and growth for Leap Automation Ltd, an emerging leader in low-cost industrial AI robotics.

Celestia has announced the signing of an Expression of Interest with Uzma, a leader in the energy and technology landscape of Malaysia, that marks the start of a mutual collaboration between the two commercial partners on the development of advanced space satellite solutions for the South East Asia region.

Clean heat technology company Exergy3 has announced the successful closure of a £1m pre-seed funding round for its novel ultra-high temperature thermal energy storage system.

SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A funding round to accelerate the development of its unique peptide-based, nature-inspired bioinsecticides – the first of their kind to be developed worldwide.